Innovative inhaler available worldwide
Researchers at the University of Groningen have developed an innovative dry powder inhaler for asthma and COPD treatment. This new inhaler, the Novolizer, has many advantages over existing inhalers. The Novolizer is a good example of what the Centre for Valorization and Entrepreneurship wants to achieve.
The weekly online video magazine Unifocus highlights topics related to the University of Groningen in the fields of research and society, student life, teaching, policy and internationalization.
| Last modified: | 13 March 2020 4.32 p.m. |
More news
-
29 April 2021
Nieuwe database geeft aan welke kinderen met ADHD goed reageren op gedragstherapie
Het UMCG, VU en KU Leuven concluderen dat kinderen met ADHD die erstige symptomen van ADHD of gedragstoornis hebben of kinderen met ADHD van alleenstaande ouders voorrang moeten krijgen bij gedragstherapeutische behandelingen. Gebeurt dit niet dan...
-
16 April 2021
Taking part in Lifelines can help to prevent cardiovascular disease
Providing feedback about the health of those taking part in the long-term health study Lifelines is helping to prevent cardiovascular disease among the participants. This is the outcome of a study on 50,000 Lifelines participants by the University...
-
18 March 2021
Subsidy for UMCG research into VR exercises for more self-compassion
The UMCG has received a subsidy of €65,000 from the educational institute PPO. With these funds, treatment psychologist and postdoc researcher Elise van der Stouwe, together with Wim Veling and Marieke Pijnenborg, will begin a study into the...